Introduction
Indigenous Australians have a higher burden of chronic non-communicable conditions, including anaemia, chronic kidney disease (CKD), diabetes and cardiovascular (CV) disease than other Australians [1] . Nationally reported statistics cannot adequately represent the variability within this population, including differences between the major indigenous ethnic groups (the Aboriginal and Torres Strait Islander peoples such as body composition or dyslipidaemia profile [2, 3] ) or the geographical diversity with illness burden [4] . End stage chronic kidney disease is one chronic condition which disproportionately affects Indigenous Australian people than observed among non-Indigenous counterparts, occurring at a much younger age and for whom Indigenous females have almost twice the risk as Indigenous males [5] . It is recognised that additional mechanisms and markers of chronic disease risk are needed to explain the CV disease burden and risks within Indigenous Australian communities [6, 7] .
We recently reported an inverse association of total serum bilirubin (inclusive of the pathological range >20 µmol/L) with albumin to creatinine ratio (ACR) among participants of the eGFR Study [8] , an adult Indigenous population living in diverse regions of Northern and Central Australia, stratified for good health, diabetes and CKD. Serum bilirubin is the end product of haem degradation, has anti-oxidant properties, and in low concentration is associated with chronic cardio-metabolic disease risk [9] . Although our finding of an inverse association of ACR and bilirubin was consistent with reports of a cohort of adults with diabetes from Asia [10] , it was in contrast to findings of a United States population-based health survey which reported a positive association between albuminuria and bilirubin [11] .
The prevalence and severity of anaemia within populations is an important health indicator [12] . Anaemia is a condition frequently reported among sub-populations of Indigenous Australians [13] and is associated with diabetes and chronic kidney disease [14] . Factors contributing to anaemia thus include poor quality diet, micronutrient absorption, the impact of anaemia related to co-morbid chronic conditions and red cell destruction. We hypothesised that serum bilirubin will be
A C C E P T E D M A N U S C R I P T negatively associated with markers of cardio-metabolic disease in Indigenous
Australians, a population known to have high risk for anaemia, diabetes, premature cardiovascular disease, and chronic kidney disease.
Methods

Participants
Participants were self-identifying adult Aboriginal and Torres Strait Islander (TSI)
Australians from the baseline eGFR Study [15] , recruited from more than 20 sites in urban, regional and remote areas known to have a high background prevalence of dialysis-dependent end stage kidney (ESKD) disease. All who expressed an interest to participate were able to be stratified for inclusion, including those with diabetes or CKD. We excluded pregnant or breast feeding women, or participants with rapidly changing kidney function. 
Measures
Detailed descriptions of the methods have been previously described. In brief, diabetes status was confirmed by the medical record or glycated haemoglobin (HbA1c) defined as ≥6.5% or ≥48mmol/mol [16] . Current smoking status was selfreported and categorically described. The remoteness index score (ARIA) >10.53
indicated a community/town in very remote Australia [17] . Medication prescription was recorded from participants and confirmed by the medical record.
Measurements of resting blood pressure, height, weight, waist and hip Figure S1) . Of the 600 participants with a Hb result, the first 29/600 participants only had a Hb result requested, whilst subsequent participants also had a mean corpuscle volume (MCV) available (n=568). Using our crude criteria, 86/600 (14.3%) participants were identified with suspected liver disease as follows: daily alcohol consumption, high weekly alcohol consumers, serum ALT more than two times the upper limit of normal of 44 u/L, serum total bilirubin more than two times the upper normal limit of 20 µmol/L, and serum albumin less than 35g/L (n=16, 33, 10, 2 and 25 respectively).
Statistical Analyses
Descriptive characteristics of participants were reported by Indigenous status (Aboriginal or TSI) and, within each indigenous group, across tertiles of bilirubin.
Categorical variables were described with a percentage and continuous variables, when normally distributed, with mean and standard deviation (SD). Continuous variables with a skewed distribution were described with median and interquartile range (IQR). Serum bilirubin was also log-transformed to achieve a normal distribution in values. In order to minimise the impact of multiple comparisons we by first exploring the association of each independent factor with log-bilirubin.
Subsequently we built multivariable models that included all the potentially significant factors (p<0.1 on linear regression models) and assessed the extent to which each model was effective at explaining the variability of the log-bilirubin by reporting the coefficient of determination (R 2 ). Sensitivity analyses exploring the impact of suspected liver disease was also explored. Statistical analyses were performed using Stata v14 (Stata Corporation, College Station, TX).
Results
Diabetes, albuminuria (without significantly impaired eGFR) and hypertension
were prominent findings observed among the 594 participants (Table 1) .
Aboriginal participants, who comprised 71% of the study cohort, had a higher frequency of anaemia, albuminuria and GFR<60 ml/min/1.73m 2 than TSI participants. We examined the characteristics of males and females separately by tertile of bilirubin ( Table 2, supplementary Table S1 and S2.
Bilirubin
Anaemia
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Regression modelling
In unadjusted linear regression modelling among all participants, log-bilirubin was significantly and positively associated with: total cholesterol, Hb, MCV, ALT, cystatin C, triglycerides, remoteness index, and inversely associated with: ALP, albumin, ACE inhibitor-ARB use, statin use, urea, creatinine, ACR, diabetes, triglycerides, microscopic haemoglobinuria, WHR, total protein and aspirin use. In the final multivariate regression model (Table 4) , serum log-bilirubin was positively associated with Hb and total cholesterol and inversely associated with ACR and triglycerides, even after excluding participants with suspected liver disease ( Figure   2 ). Furthermore, of the variables inversely associated with log-bilirubin, Aboriginal
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ethnicity and serum triglycerides explained a higher proportion of the variance than ACR (12.6%, 2.3%, 1.1%). Conversely, haemoglobin concentration and total cholesterol were each positively associated with log-bilirubin (each explaining 4.5% and 1.2%) of the explained variance of log-bilirubin.
Discussion
We report four key findings in this analysis of associations between bilirubin and the chronic conditions of diabetes, CKD and anaemia, in a cohort of 594
Indigenous Australians recruited from more than twenty sites. First serum logbilirubin was positively associated with haemoglobin concentration, and anaemia was also commonly observed in this cohort. Second, log-bilirubin concentrations was positively associated with total cholesterol and inversely associated with triglycerides. Third, the association between serum log-bilirubin and markers of 
Bilirubin is proportional to haemoglobin concentration
Serum bilirubin was positively associated with haemoglobin concentration among participants, explaining 4.5% of the total variance in the multivariate regression model, and anaemia was also commonly observed in this cohort. Anaemia was more frequently observed in participants with diabetes (in 23%) and lower eGFR (66% of adults with eGFR<30 ml/min/1.73m 2 ), which is a relationship that is consistent with other studies [14] . In the present analysis, the normal MCV result ACCEPTED MANUSCRIPT
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was suggestive of either anaemia of chronic disease, whilst the low MCV result was consistent with iron deficiency or potentially a thalassaemia trait [26] . It was not possible to further examine this without iron studies, dietary information, Hb electrophoresis or examine for intestinal parasites including strongyloidiasis [27] , which is a prevalent condition associated with iron deficiency anaemia in this population, without information on the presence or absence of eosinophilia. Lack of access to daily fruit and vegetables is an important modifiable contributor to cardiovascular disease in many populations [28] , and in adults with CKD, uncorrected anaemia is strongly linked with the development of cardiovascular disease outcomes [29] . Our findings highlight the association between anaemia and adverse health among a cohort of Aboriginal and Torres Strait Islander adults recruited across a range of good health, diabetes and chronic kidney disease.
Bilirubin & chronic disease risk associations
Dyslipidaemia (including hyper-triglyceridaemia, low HDL cholesterol and high non-HDL cholesterol) is an important cardiovascular disease risk marker [2, 9, 30] documented in both developed and developing countries internationally [28] .
Serum bilirubin levels have been associated with cardiovascular risk; hyperbilirubinaemia, such as occurs in Gilbert's syndrome (a genetic mutation in the enzyme UGT1A which metabolises bilirubin) has been associated with lower cardiovascular disease risk, independent of the lipoprotein profile [31] , and lower serum bilirubin concentrations are recognised as a marker of cardiovascular disease risk [9] . We hypothesised that serum bilirubin was associated with markers of chronic disease, including CV disease, CKD and anaemia among Indigenous Australians. We have shown bilirubin was inversely associated with triglycerides, but bilirubin was also positively association with total cholesterol.
We adjusted for numerous indicators of CV risk in the multivariate regression model by inclusion of age, blood pressure, adiposity, HbA1c, ACEI-ARB use, serum CRP and serum albumin. Our finding of an inverse association between serum logbilirubin and triglycerides is consistent with other health screening surveys [32] .
Cardiovascular disease risk management guidelines promote reduction in total cholesterol using statins as a first agent [33] . HMG-CoA reductase inhibitors
A C C E P T E D M A N U S C R I P T
(statins) are reported to have a low negative effect on total bilirubin concentrations in individuals [34] , however the final multivariate regression model was strengthened when limited to participants who were prescribed a statin. We suggest reverse causality may be one explanation for the positive association between bilirubin and total cholesterol in this cross-sectional study. Our findings remain unique, as other studies have not examined the association of bilirubin when adjusted for both Hb concentration and markers of CKD.
Bilirubin and markers of chronic kidney disease
This analysis explored more deeply the associations of albuminuria as part of its cardio-metabolic risk in this cohort [8] . Log-bilirubin was inversely associated with ACR in the multivariate regression analysis (coefficient -0.004, p=0.001), where 1 mg/mmol higher ACR was associated with 0.004 units lower log-bilirubin, or 1.00 µmol/L lower serum total bilirubin. In this cohort a wide range of ACR was observed (normo to macroalbuminuic range), thus ACR in the macroalbuminuria range is associated with lower bilirubin, and likely to be clinically meaningful. Our finding of an inverse association of bilirubin and ACR was consistent with reports from Korea among adults with and without diabetes [35] and Taiwanese adults [24] . In contrast to our findings, we note the positive association between bilirubin and albuminuria among a United States study [11] . It is possible that these different associations between bilirubin and albuminuria may be explained by the clinical and biochemical characteristics of the cohorts, including differences in median bilirubin concentrations observed (United States cohort v our cohort:
(median (IQR): 12(10.3-14.7) v 6(5, 9)µmol/L).
In this analysis we have shown that bilirubin was not significantly explained by other measures of kidney function (Cystatin C, serum creatinine or eGFR). Thus the association of low bilirubin was not likely to be explained by inhibiting effects of Cystatin C which has been shown to attenuate anti-inflammatory processes in the setting of low GFR [37] . We suggest the inverse association of serum total bilirubin and ACR more strongly reflects cardio-metabolic risk, since bilirubin was not explained by other measures of kidney function.
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Riphagen et al. reported baseline bilirubin levels were inversely associated with both ACR and eGFR [38] , however our analysis showed bilirubin was only inversely associated with ACR. Our study findings remain important, since Riphagen et al.
further reported low bilirubin concentration was associated with progression of diabetic kidney disease to ESKD, which has important implications for CKD and CV risk progression among Aboriginal and Torres Strait Islander peoples. We acknowledge there are several factors of interest to bilirubin production in adults with chronic kidney disease (erythrocyte lifespan [39] , albumin production, albumin-bilirubin binding, enzymatic degradation of haemoglobin in adults with renal disease [40] ), which are unlikely to significantly explain low bilirubin concentrations, since our participants were recruited from the community without acute illness and had stable kidney function.
Bilirubin concentrations between populations
Our data shows Aboriginal participants had lower bilirubin values than TSI reported by Lee et al. [24] and Shin et al. [35] ) were driven by ethnic population differences or study design. Although genetics can influence the intrinsic activity
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of bilirubin metabolism (haem-oxygenase, HO-1, and biliverdin reductase), genetic assessments were not measured in these studies. Genetic variation studies (including mendelian randomisation) are one approach which may assist in addressing study confounding, to elucidate the causal relationships between gene products and outcomes. A recent meta-analysis confirmed differences in HO-1 genotype length between Asian and Caucasian populations, which the authors suggest are likely to impact on the interpretation of cardiovascular disease risk in large multiethnic studies [42] . Furthermore, by modelling the bilirubin gene UGT1A1*28, it was recently shown that bilirubin affects the cardiovascular system through vasomotor tone and artery reactivity [43] .
Weaknesses and Strengths
We acknowledge some limitations in this study. First we used a cross-sectional study design with volunteering participants, which introduces potential for bias and explores associations of low serum bilirubin and not causality. Only serum total bilirubin was used in this analysis as we recognise that fractionated bilirubin measures are less clinically useful at low concentration of bilirubin. Urine ACR was based on the assessment of a single urine sample. Although all laboratories were nationally accredited, we acknowledge that differences in analytical methods for serum total bilirubin may make comparisons between laboratories difficult. We did not undertake a sensitivity analysis for bilirubin concentration by laboratory or region as participants were not representative of all strata (or population representative) in all study sites, and thus not strata-representative in every laboratory catchment area. In the multivariate regression model, the association of total bilirubin and total cholesterol (p=0.038) is regarded as borderline statistical significance given the number of tests performed. Classification of adults with suspected liver disease may be enhanced by additional medical history (cirrhosis, viral hepatitis) and a detailed alcohol record [24] . We were unable to determine corroborating details of other factors which contribute to the balance of anti-oxidant and oxidant stress among participants including poor quality atherogenic diets low in micronutrients [28] , physical inactivity, a comprehensive assessment of tobacco and alcohol use, or presence and cause of chronic low
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grade inflammation beyond the serum C-reactive protein [44] . These are often manifestations of communities in significant lifestyle transition and or poverty, thus disproportionately affecting minority and indigenous peoples in modernising countries [45, 46] . However, this study is unique as the only report describing the associations of serum bilirubin with metabolic risks in a community-based cohort of Aboriginal and or TSI people, and highlights modifiable associations of low serum bilirubin concentrations with ACR and low Hb concentration.
Conclusions
Our findings show that serum bilirubin is associated with markers of chronic disease, including CKD, dyslipidaemia, albuminuria and anaemia among A C C E P T E D M A N U S C R I P T Figure 2 . Bilirubin concentration by anaemia and albuminuria group categories, which are fully adjusted for independent variables identified in the multivariate regression model. Bilirubin expressed as geometric mean (95% confidence intervals). . Data missing for* diabetes (n=593); hypertension (n=589); albuminuria (n=571); current smoking (n=585); alcohol excess (n=454); BMI (n=591); Cystatin C (n=545); ACR (n=571); HbA1c (n=588); MCV (n=562); blood pressure (n=588); BMI (n=591); WHR (n=566). A C C E P T E D M A N U S C R I P T 
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